IE46257L - 2-substituted-15-heteroaryl-16,17,18,19,20-¹pentanorprostaglandins - Google Patents

2-substituted-15-heteroaryl-16,17,18,19,20-¹pentanorprostaglandins

Info

Publication number
IE46257L
IE46257L IE771785A IE178577A IE46257L IE 46257 L IE46257 L IE 46257L IE 771785 A IE771785 A IE 771785A IE 178577 A IE178577 A IE 178577A IE 46257 L IE46257 L IE 46257L
Authority
IE
Ireland
Prior art keywords
substituted
heteroaryl
heterocyclo
omega
aryl
Prior art date
Application number
IE771785A
Other versions
IE46257B1 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IE46257L publication Critical patent/IE46257L/en
Publication of IE46257B1 publication Critical patent/IE46257B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5407—Acyclic saturated phosphonium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C07F9/65517—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Novel heterocyclo - omega - substituted in the 2 position to aryl . [FR2362849A1]
IE1785/77A 1976-08-27 1977-08-26 2-substituted-15-heteroaryl-16,17,18,19,20-pentanorprostaglandins IE46257B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71810776A 1976-08-27 1976-08-27

Publications (2)

Publication Number Publication Date
IE46257L true IE46257L (en) 1978-02-27
IE46257B1 IE46257B1 (en) 1983-04-20

Family

ID=24884845

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1785/77A IE46257B1 (en) 1976-08-27 1977-08-26 2-substituted-15-heteroaryl-16,17,18,19,20-pentanorprostaglandins

Country Status (9)

Country Link
JP (1) JPS5328159A (en)
BE (1) BE858147A (en)
DE (1) DE2737808A1 (en)
DK (1) DK379477A (en)
FR (1) FR2362849A1 (en)
GB (1) GB1542569A (en)
IE (1) IE46257B1 (en)
LU (1) LU78037A1 (en)
NL (1) NL7709444A (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200000671T2 (en) * 1997-09-09 2000-07-21 The Procter & Gamble Company Aromatic C16-C20-substituted tetrahydro prostaglandins useful as FP agonists.
SK3382000A3 (en) * 1997-09-09 2000-10-09 Procter & Gamble A compound having structure of aromatic substituted prostaglandins and its use for the treatment of bone disorders
SK3362000A3 (en) * 1997-09-09 2000-10-09 Procter & Gamble A compound analogous to prostaglandin f and use thereof
NZ513825A (en) 1999-03-05 2001-09-28 Procter & Gamble C 16 unsaturated FP-selective prostaglandins analogs
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
JP6111672B2 (en) * 2013-01-10 2017-04-12 株式会社ニコン Photomask substrate and photomask

Also Published As

Publication number Publication date
BE858147A (en) 1978-02-27
GB1542569A (en) 1979-03-21
JPS5539554B2 (en) 1980-10-13
NL7709444A (en) 1978-03-01
IE46257B1 (en) 1983-04-20
FR2362849B1 (en) 1980-07-11
JPS5328159A (en) 1978-03-16
DK379477A (en) 1978-02-28
FR2362849A1 (en) 1978-03-24
DE2737808A1 (en) 1978-03-16
LU78037A1 (en) 1979-05-23

Similar Documents

Publication Publication Date Title
AU505080B2 (en) 2-piperazinyl-6, 7-dimethoxyquinazolines
AU503557B2 (en) N, n' alkylene-bis-tetrabromo-phthalimides
AU511569B2 (en) 9-thia, 12-azaprostanoic acids
AU503871B2 (en) 1. 2-benzothiazolin-3-one
AU517020B2 (en) 10, 19-dihydro-vitamin d compounds
IE46257L (en) 2-substituted-15-heteroaryl-16,17,18,19,20-¹pentanorprostaglandins
AU508738B2 (en) 8-oxo-3-oxa-l-azabicycio [4,2,0] - cotane derivatives
AU508007B2 (en) 1, 5-Disubstituted-2-Pyrrolidones
AU512404B2 (en) 2, 6-Methano-2H-l-Benzoxocins
AU512313B2 (en) y, y, Disubstituted-5-valerolactones
AU515495B2 (en) 5, 5-trimethylhexanoyl-ferrocene
AU500386B2 (en) 1,2,6-thidiazinones
AU505974B2 (en) 3', 4'-dideoxykanamcin b
AU511988B2 (en) O-ethyl-s-n-propyl-0,2,2,2-trihaloethy_phosphoro-thiolates/thionothiolates
AU511827B2 (en) 5-anyl-3, 6-dihydro-l, 3, 4-oxadiazin-2-ones
AU507282B2 (en) 3, 3-Dimethylpent-4-Endic Acid
AU517895B2 (en) 1, 3-dihydro-1-dimethyl phosphinylalkyl 3 phenylspiro ( iosbenzofurn)s
AU514741B2 (en) 5,6-dehydropenicillins
AU506922B2 (en) N-6-chlorunicotinoyl-d, l-homocysteing thiolactonne
AU524600B2 (en) 2,6-methano-3-benzazocines
GB1546347A (en) 5,11-diazatetracyclo-(6.2.2.02,7 04,9)-dodecanes
MY8200244A (en) 2,3-dihydro-2-oxo-3-benzo[b]thiophenecarboxides
AU488952B2 (en) 2. 4-diamino-5-benzylpyrimidines
AU520088B2 (en) 1, 2, 3, 4-tetrahydro-naphthalenes
IE45950L (en) 7ó-halosteroids.